Related references
Note: Only part of the references are listed.Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial
R. Salgo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Incidence and Clinical Predictors of a Subsequent Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients With a First Nonmelanoma Skin Cancer A Multicenter Cohort Study
Gianpaolo Tessari et al.
ARCHIVES OF DERMATOLOGY (2010)
First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients
Katarzyna A. Mackenzie et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Aggressive Behavior of Nonmelanotic Skin Cancers in Solid Organ Transplant Recipients
David G. Lott et al.
TRANSPLANTATION (2010)
Minimizing the Risk of Posttransplant Malignancy
Josep M. Campistol
TRANSPLANTATION (2009)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: A case series with 15-year follow-up
Anne Lemy et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
BK virus nephritis after renal transplantation
Aaron Dall et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies
Karl M. Wissing et al.
TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability
G. E. Koehl et al.
TRANSPLANTATION (2007)
Cancer incidence before and after kidney transplantation
Claire M. Vajdic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Post-transplant de novo malignancies in renal transplant recipients:: the past and present
H. Myron Kauffman et al.
TRANSPLANT INTERNATIONAL (2006)
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients
Gerhard Opelz et al.
TRANSPLANTATION (2006)
Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma
S Euvrard et al.
TRANSPLANTATION (2006)
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil
R Robson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
AC Webster et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Azathioprine and UVA light generate mutagenic oxidative DNA damage
P O'Donovan et al.
SCIENCE (2005)
Lymphomas after solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation
M Guba et al.
TRANSPLANTATION (2004)
Cancer after kidney transplantation in the United States
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Incidence of cancer after kidney transplant: Results from the North Italy Transplant program
P Pedotti et al.
TRANSPLANTATION (2003)
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation
WS Cherikh et al.
TRANSPLANTATION (2003)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)